home > domains > cad-hcptreatmentinfo.com
Description: BRILINTA® (ticagrelor) is indicated for treatment in patients with high-risk coronary artery disease (CAD) without history of MI or stroke.
For US Health Care Professionals
Change Indication
REQUEST A REP OR SAMPLES